SEARCH

SEARCH BY CITATION

References

  • Asplin, K.E., Sillence, M.N., Pollitt, C.C. and McGowan, C.M. (2007) Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Vet. J. 174, 530-535.
  • Bailey, S.R., Menzies-Gow, N.J., Harris, P.A., Habershon-Butcher, J.L., Crawford, C., Berhane, Y., Boston, R.C. and Elliott, J. (2007) Effect of dietary fructans and dexamethasone administration on the insulin response of ponies predisposed to laminitis. J. Am. vet. med. Ass. 231, 1365-1373.
  • Braggio, S., Barnaby, R.J., Grossi, P. and Cugola, M. (1996) A strategy for validation of bioanalytical methods. J. Pharm. Biomed. Anal. 14, 375-388.
  • Brunton, S.A., Davis, S.N. and Renda, S.M. (2006) Early intervention to achieve optimal outcomes in type 2 diabetes: a case presentation. Clin. Cornerstone 8, Suppl. 2, S6-S18.
  • Carter, R.A., Treiber, K.H., Geor, R.J., Douglass, L. and Harris, P.A. (2009) Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies. Equine vet. J. 41, 171-178.
  • Caumo, A. and Luzi, L. (2004) First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am. J. Physiol. Endocrinol. Metab. 287, E371-385.
  • Faber, O.K., Hagen, C., Binder, C., Markussen, J., Naithani, V.K., Blix, P.M., Kuzuya, H., Horwitz, D.L., Rubenstein, A.H. and Rossing, N. (1978) Kinetics of human connecting peptide in normal and diabetic subjects. J. clin. Invest. 62, 197-203.
  • Firshman, A.M. and Valberg, S.J. (2007) Factors affecting clinical assessment of insulin sensitivity in horses. Equine vet. J. 39, 567-575.
  • Frank, N., Elliott, S.B., Brandt, L.E. and Keisler, D.H. (2006) Physical characteristics, blood hormone concentrations, and plasma lipid concentrations in obese horses with insulin resistance. J. Am. vet. med. Ass. 228, 1383-1390.
  • Freestone, J.F., Wolfsheimer, K.J., Kamerling, S.G., Church, G., Hamra, J. and Bagwell, C. (1991) Exercise induced hormonal and metabolic changes in Thoroughbred horses: effects of conditioning and acepromazine. Equine vet. J. 23, 219-223.
  • Henneke, D.R., Potter, G.D., Kreider, J.L. and Yeates, B.F. (1983) Relationship between condition score, physical measurements and body fat percentage in mares. Equine vet. J. 15, 371-372.
  • Henquin, J.C., Ishiyama, N., Nenquin, M., Ravier, M.A. and Jonas, J.C. (2002) Signals and pools underlying biphasic insulin secretion. Diabetes 51, Suppl. 1, S60-67.
  • Hoffman, R.M., Boston, R.C., Stefanovski, D., Kronfeld, D.S. and Harris, P.A. (2003) Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. J. anim. Sci. 81, 2333-2342.
  • Hovorka, R., Koukkou, E., Southerden, D., Powrie, J.K. and Young, M.A. (1998) Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule. Diabetologia 41, 548-554.
  • Hwu, C.M., Kwok, C.F., Chiang, S.C., Wang, P.Y., Hsiao, L.C., Lee, S.H., Lin, S.H. and Ho, L.T. (2001) A comparison of insulin suppression tests performed with somatostatin and octreotide with particular reference to tolerability. Diabetes Res. Clin. Pract. 51, 187-193.
  • Johnson, P.J., Scotty, N.C., Wiedmeyer, C., Messer, N.T. and Kreeger, J.M. (2005) Diabetes mellitus in a domesticated Spanish mustang. J. Am. vet. med. Ass. 226, 584-588, 542.
  • Jones, C.N., Pei, D., Staris, P., Polonsky, K.S., Chen, Y.D. and Reaven, G.M. (1997) Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J. clin. Endocrinol. Metabol. 82, 1834-1838.
  • Kjems, L.L., Christiansen, E., Volund, A., Bergman, R.N. and Madsbad, S. (2000) Validation of methods for measurement of insulin secretion in humans in vivo. Diabetes 49, 580-588.
  • Kjems, L.L., Volund, A. and Madsbad, S. (2001) Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods. Diabetologia 44, 1339-1348.
  • Kronfeld, D.S., Treiber, K.H. and Geor, R.J. (2005) Comparison of nonspecific indications and quantitative methods for the assessment of insulin resistance in horses and ponies. J. Am. vet. med. Ass. 226, 712-719.
  • Low, M.J. (2004) Clinical endocrinology and metabolism. The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders. Best Pract. Res. Clin. Endocrinol. Metab. 18, 607-622.
  • Ludvigsen, E. (2007) Somatostatin receptor expression and biological functions in endocrine pancreatic cells: review based on a doctoral thesis. Ups. J. Med. Sci. 112, 1-20.
  • Mittelman, S.D., Van Citters, G.W., Kim, S.P., Davis, D.A., Dea, M.K., Hamilton-Wessler, M. and Bergman, R.N. (2000) Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes 49, 2116-2125.
  • Polonsky, K., Jaspan, J., Pugh, W., Cohen, D., Schneider, M., Schwartz, T., Moossa, A.R., Tager, H. and Rubenstein, A.H. (1983) Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J. clin. Invest. 72, 1114-1123.
  • Polonsky, K.S., Licinio-Paixao, J., Given, B.D., Pugh, W., Rue, P., Galloway, J., Karrison, T. and Frank, B. (1986) Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J. clin. Invest. 77, 98-105.
  • Stefanovski, D., Moate, P.J. and Boston, R.C. (2003) WinSAAM: a windows-based compartmental modeling system. Metabolism 52, 1153-1166.
  • Tiley, H.A., Geor, R.J. and McCutcheon, L.J. (2007) Effects of dexamethasone on glucose dynamics and insulin sensitivity in healthy horses. Am. J. vet. Res. 68, 753-759.
  • Toth, F., Frank, N., Elliott, S.B., Geor, R.J. and Boston, R.C. (2008) Effects of an intravenous endotoxin challenge on glucose and insulin dynamics in horses. Am. J. vet. Res. 69, 82-88.
  • Toth, F., Frank, N., Geor, R.J. and Boston, R.C. (2010) Effects of pretreatment with dexamethasone or levothyroxine sodium on endotoxin-induced alterations in glucose and insulin dynamics in horses. Am. J. vet. Res. 71, 60-68.
  • Treiber, K.H., Kronfeld, D.S., Hess, T.M., Boston, R.C. and Harris, P.A. (2005) Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am. J. vet. Res. 66, 2114-2121.
  • Treiber, K.H., Kronfeld, D.S., Hess, T.M., Byrd, B.M., Splan, R.K. and Staniar, W.B. (2006) Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J. Am. vet. med. Ass. 228, 1538-1545.
  • Wahren, J., Ekberg, K., Johansson, J., Henriksson, M., Pramanik, A., Johansson, B.L., Rigler, R. and Jornvall, H. (2000) Role of C-peptide in human physiology. Am. J. Physiol. Endocrinol. Metab. 278, E759-768.
  • Wastney, M.E., Patterson, B.H., Linares, O.A., Greif, P.C. and Boston, R.C. (1999) Investigating Biological Systems using Modeling: Strategies and Software, Academic Press, New York.
  • Wilcox, G. (2005) Insulin and insulin resistance. Clin. Biochem. Rev. 26, 19-39.
  • Zavaroni, I., Deferrari, G., Lugari, R., Bonora, E., Garibotto, G., Dall'Aglio, E., Robaudo, C. and Gnudi, A. (1987) Renal metabolism of C-peptide in man. J. Clin. Endocrinol. Metab. 65, 494-498.